Xinfeng capsule-containing serum relieves platelet activation by inhibiting VEGFA/SDF-1/CXCR4 pathway in patients with ankylosing spondylitis

FANG Yanyan; LIU Jian; WAN Lei; DONG Wenzhe; WEN Jianting

doi:10.13431/j.cnki.immunol.j.20190108

Home>Articles>Xinfeng capsule-containing serum relieves platelet activation by inhibiting VEGFA/SDF-1/CXCR4 pathway in patients with ankylosing spondylitis

DOI: 10.13431/j.cnki.immunol.j.20190108

Xinfeng capsule-containing serum relieves platelet activation by inhibiting VEGFA/SDF-1/CXCR4 pathway in patients with ankylosing spondylitis

FANG Yanyan

LIU Jian

WAN Lei

DONG Wenzhe

WEN Jianting

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 691-696 )

Immunological Journal

PKUISTIC

ISSN：1000-8861

Year, Vol.(Issue)：2019,35(8)